Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Abstract

After 15 years of follow-up, prostate cancer-specific mortality was low regardless of the treatment assigned. Thus, the choice of therapy involves weighing trade-offs between benefits and harms associated with treatments for localized prostate cancer. (Funded by the National Institute for Health and Care Research; ProtecT Current Controlled Trials number, ISRCTN20141297; ClinicalTrials.gov number, NCT02044172.).

Keywords

Prostate cancerMedicineRadiation therapyCancerGeneral surgeryOncologySurgeryInternal medicine

Affiliated Institutions

Related Publications

National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000

Patricia J. Eifel , Jan Axelson , Janitha Costa +11 more

The panel concludes that decisions regarding adjuvant hormonal therapy should be based on the presence of hormone receptor protein in tumor tissues. Adjuvant hormonal therapy sh...

2001 JNCI Journal of the National Cancer I... 894 citations

Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

James Larkin , Vanna Chiarion‐Sileni , René González +28 more

BACKGROUND Nivolumab plus ipilimumab or nivolumab alone resulted in longer progression-free and overall survival than ipilimumab alone in a trial involving patients with advance...

2019 New England Journal of Medicine 3500 citations

Publication Info

Year: 2023
Type: article
Volume: 388
Issue: 17
Pages: 1547-1558
Citations: 605
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

605

OpenAlex

Cite This

APA Style

                            
                                
                                    Freddie C. Hamdy, 
                                
                                    Jenny Donovan, 
                                
                                    J. Athene Lane
                                
                                et al.
                            
                            (2023). 
                            Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer. 
                            New England Journal of Medicine
                            , 388
                            (17)
                            , 1547-1558.
                            https://doi.org/10.1056/nejmoa2214122
                        

Identifiers

DOI: 10.1056/nejmoa2214122